Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nicolas Kint, Sophie Vlayen & Michel Delforge. (2019) The treatment of multiple myeloma in an era of precision medicine. Expert Review of Precision Medicine and Drug Development 4:3, pages 153-162.
Read now
Read now
Articles from other publishers (4)
Francesca Gay, Giuseppe Bertuglia & Roberto Mina. (2023) A rational approach to functional high-risk myeloma. Hematology 2023:1, pages 433-442.
Crossref
Crossref
Sahar Hadi Pour, Shamsuddin Shahid & Saad Sh. Sammen. 2023. Handbook of Hydroinformatics. Handbook of Hydroinformatics
353
377
.
Raphael Szalat, Herve Avet-Loiseau & Nikhil C. Munshi. (2016) Gene Expression Profiles in Myeloma: Ready for the Real World?. Clinical Cancer Research 22:22, pages 5434-5442.
Crossref
Crossref
C Gu, Y Yang, R Sompallae, H Xu, V S Tompkins, C Holman, D Hose, H Goldschmidt, G Tricot, F Zhan & S Janz. (2015) FOXM1 is a therapeutic target for high-risk multiple myeloma. Leukemia 30:4, pages 873-882.
Crossref
Crossref